News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
379,335 Results
Type
Article (30475)
Company Profile (129)
Press Release (348731)
Multimedia
Podcasts (28)
Webinars (5)
Section
Business (104117)
Career Advice (1201)
Deals (16485)
Drug Delivery (56)
Drug Development (49123)
Employer Resources (92)
FDA (8311)
Job Trends (8778)
News (179657)
Policy (17089)
Tag
Academia (2107)
Academic (1)
Accelerated approval (4)
Adcomms (14)
Allergies (35)
Alliances (30686)
ALS (49)
Alzheimer's disease (737)
Antibody-drug conjugate (ADC) (149)
Approvals (8358)
Artificial intelligence (177)
Autoimmune disease (17)
Automation (9)
Bankruptcy (134)
Best Places to Work (7693)
BIOSECURE Act (15)
Biosimilars (76)
Biotechnology (101)
Bladder cancer (84)
Brain cancer (29)
Breast cancer (315)
Cancer (2441)
Cardiovascular disease (69)
Career advice (1023)
Career pathing (19)
CAR-T (145)
Cell therapy (338)
Cervical cancer (22)
Clinical research (39409)
Collaboration (612)
Company closure (2)
Compensation (182)
Complete response letters (10)
COVID-19 (1529)
CRISPR (28)
C-suite (139)
Cystic fibrosis (46)
Data (1497)
Decentralized trials (2)
Denatured (5)
Depression (16)
Diabetes (120)
Diagnostics (4774)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (28)
Drug discovery (79)
Drug pricing (60)
Drug shortages (8)
Duchenne muscular dystrophy (35)
Earnings (37393)
Editorial (19)
Employer branding (14)
Employer resources (80)
Events (56089)
Executive appointments (403)
FDA (9158)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (464)
Gene editing (52)
Generative AI (11)
Gene therapy (133)
GLP-1 (272)
Government (3281)
Grass and pollen (2)
Guidances (113)
Healthcare (13388)
Huntington's disease (4)
IgA nephropathy (6)
Immunology and inflammation (67)
Indications (21)
Infectious disease (1606)
Inflammatory bowel disease (70)
Inflation Reduction Act (4)
Influenza (25)
Intellectual property (54)
Interviews (175)
IPO (7797)
IRA (21)
Job creations (1396)
Job search strategy (920)
Kidney cancer (11)
Labor market (15)
Layoffs (225)
Leadership (9)
Legal (3028)
Liver cancer (81)
Lung cancer (348)
Lymphoma (151)
Machine learning (7)
Management (29)
Manufacturing (188)
MASH (37)
Medical device (5730)
Medtech (5732)
Mergers & acquisitions (8996)
Metabolic disorders (266)
Multiple sclerosis (33)
NASH (2)
Neurodegenerative disease (30)
Neuropsychiatric disorders (6)
Neuroscience (971)
NextGen: Class of 2025 (4414)
Non-profit (4006)
Now hiring (8)
Obesity (110)
Opinion (136)
Ovarian cancer (83)
Pain (45)
Pancreatic cancer (90)
Parkinson's disease (66)
Partnered (17)
Patents (119)
Patient recruitment (79)
Peanut (12)
People (30272)
Pharmaceutical (27)
Pharmacy benefit managers (11)
Phase I (13748)
Phase II (17084)
Phase III (12496)
Pipeline (947)
Policy (88)
Postmarket research (1414)
Preclinical (5838)
Press Release (35)
Prostate cancer (114)
Psychedelics (9)
Radiopharmaceuticals (247)
Rare diseases (189)
Real estate (2930)
Recruiting (33)
Regulatory (12135)
Reports (21)
Research institute (2006)
Resumes & cover letters (168)
RNA editing (2)
RSV (21)
Schizophrenia (37)
Series A (73)
Series B (40)
Service/supplier (3)
Sickle cell disease (33)
Special edition (6)
Spinal muscular atrophy (51)
Sponsored (17)
Startups (1891)
State (2)
Stomach cancer (16)
Supply chain (34)
Tariffs (28)
The Weekly (23)
Vaccines (386)
Venture capitalists (17)
Weight loss (56)
Women's health (26)
Worklife (6)
Date
Last 7 days (545)
Last 30 days (1750)
Last 365 days (19262)
2025 (6906)
2024 (20844)
2023 (23399)
2022 (31563)
2021 (34136)
2020 (33120)
2019 (30137)
2018 (22473)
2017 (17754)
2016 (17238)
2015 (20027)
2014 (14887)
2013 (12206)
2012 (12845)
2011 (13558)
2010 (11854)
Location
Africa (452)
Alabama (24)
Alaska (4)
Arizona (101)
Arkansas (8)
Asia (24246)
Australia (3980)
California (3540)
Canada (1204)
China (444)
Colorado (149)
Connecticut (172)
Delaware (115)
Europe (49146)
Florida (524)
Georgia (103)
Idaho (36)
Illinois (346)
India (19)
Indiana (233)
Iowa (6)
Japan (101)
Kansas (48)
Kentucky (22)
Louisiana (6)
Maine (13)
Maryland (592)
Massachusetts (2469)
Michigan (89)
Minnesota (171)
Mississippi (2)
Missouri (70)
Montana (24)
Nebraska (16)
Nevada (43)
New Hampshire (45)
New Jersey (1134)
New Mexico (19)
New York (1170)
North Carolina (555)
North Dakota (2)
Northern California (1623)
Ohio (115)
Oklahoma (4)
Oregon (16)
Pennsylvania (744)
Puerto Rico (6)
Rhode Island (16)
South America (620)
South Carolina (10)
South Dakota (1)
Southern California (1341)
Tennessee (45)
Texas (681)
United States (13668)
Utah (91)
Virginia (93)
Washington D.C. (39)
Washington State (380)
West Virginia (3)
Wisconsin (47)
379,335 Results for "national comprehensive cancer network".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Y-mAbs Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma to Include Naxitamab-gqgk (DANYELZA®)
May 7, 2025
·
7 min read
Press Releases
Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening
March 20, 2025
·
3 min read
Press Releases
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
February 17, 2025
·
5 min read
Press Releases
National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment
November 4, 2024
·
3 min read
Business
Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN--Journal of the National Comprehensive Cancer Network
Daniel M. Geynisman, MD, is being announced as the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network.
May 16, 2024
·
5 min read
Business
National Comprehensive Cancer Network Awards Champions for Excellence and Outstanding Contributions in Cancer Care
The National Comprehensive Cancer Network® is announcing 2024 award recipients that include individuals and groups who have made significant and noteworthy impacts on improving cancer care and supporting NCCN’s mission to help all people with cancer to live better lives.
April 17, 2024
·
6 min read
Lone Star Bio
Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that it will present a poster at the National Comprehensive Cancer Network (NCCN) 2024 Annual Conference, which will be held April 5-7, 2024, in Orlando, Florida.
March 27, 2024
·
5 min read
Press Releases
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network
April 3, 2025
·
3 min read
Press Releases
Outcomes4Me and the National Comprehensive Cancer Network (NCCN) Expand Collaboration to Improve Outcomes for Patients Diagnosed with Prostate Cancer
November 21, 2024
·
7 min read
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
1 of 37,934
Next
